Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2
Status:
Not yet recruiting
Trial end date:
2023-11-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in
adult participants with diagnosis of chronic hand eczema (CHE) and moderate to severe disease
activity (Investigator's Global Assessement (IGA) of CHE score 3 or 4).